Abstract
Introduction. In recent decades, remarkable progress has been made in the management of stroke, including the option of thrombolysis. Unfortunately, few patients present in time to be candidates acute treatment for several reasons, including lack of knowledge about symptoms, risk factors and appropriate behavior.
Objectives. Assess level of awareness of symptoms, risk factors and behavior to be adopted in the presence of stroke or TIA.
Materials and Methods. We conducted a descriptive and population-based cross section study in the city of Manizales, in over 50 years older people interviewed in health centers and public places, which were to be hypertensive or diabetic. Then were divided in two groups, attending special programs of hypertension or DM and those without. They filled out a form with open questions about the symptoms and spontaneous knowledge of risk factors (RF) and then select from a list correct or incorrect answers about symptoms or RF, that they knew. It was asked the behavior they will adopt in front stroke and TIA, and if they knew existence of a thrombolytic therapy.
Results. Were interviewed 213 people aged between 50 and 91 years (X 65.7 ± 12 years). Women accounted for 67.6% of the sample and 53% belonged to special programs. 65.3% didn't know symptoms and 54% no RF spontaneously. Hypertension was the most cited RF, while DM was in a low percentage. The level of ignorance was the same between younger and older than 65 years, or between those who attended to special programs. One third (65%) had obtained information from non- medical fonts, and there was not significant difference between those who were or were not in programs. Just 11.7% of people would go to emergency room if was suffering a stroke, the other adopted wrong behaviors. None of the respondents knew of the existence of fibrinolytic therapy.
Conclusion. There is alarming ignorance of stroke symptoms and RF in general population, even in high risk segments such as hypertensive and diabetics patients. Given this reality, it is urgent to improve the information provided to patients and community, both by health professionals as campaigns in mass media and other strategies that can be implemented in our country.
References
BONITA R. Epidemiology of stroke. Lancet. 1992; 339: 342-44.
World Stroke Organization. World Stroke Campaign. 2011 (citado el 3 de agosto de 2011). Disponible en: http://www.worldstrokecampaign.org
SILVA F, ZARRUK JG, QUINTERO C, ARENAS W, RUEDA-CLAUSEN C F,SILVA SY, ESTUPIÑáN AM. Enfermedad cerebrovascular en Colombia. Rev Colomb Cardiol 2006; 13: 85-89.
URIBE CS, JIMÉNEZ I, MORA MO. Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993). Rev Neurol 1997;25: 1008-12.
DíAZ R, RUANO MI, CHACÓN JA, VERA A. Perfil neuroepidemiológico en la zonacentro del departamento de Caldas (Colombia), años 2004-2005. Rev Neurol 2006;43: 646-52.
ZÚÑIGA A, ANTOLíNEZ BR. Prevalencia de enfermedades neurológicas en Jamundí, Valle, Colombia, 1984. Colombia Médica 1986; 17: 151-153.
PRADILLA G, VESGA BE, LEÓN-SARMIENTO FE, BAUTISTA LE, NÚÑEZ LC, VESGA E, ET AL. Neuroepidemiología en el oriente colombiano. Rev Neurol 2002; 34:1035-1043.
O'DONNELL MJ, XAVIER D, LIU L, ZHANG H, CHIN SL, PURNIMA RM, ET AL. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (The INTERSTROKE study): a asecontrol study. Lancet 2010.10; 376: 112-123.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
GRAHAM GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice. A metaanalysis of safety data. Stroke 2003; 34:2847-2850.
HACKE W, KASTE M, BLUHMKI E, BROZMAN M, DÁVALOS A, GUIDETTI D, ET AL. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 ;359 :1317-1329.
WILLIAMS LS, BRUNO A, ROUCH D, MARRIOTT DJ. Stroke patients' knowledge of stroke. Influence on time to presentation. Stroke 1997; 28: 912-915.
PÉREZ DE LA OSSA-HERRERO N. El acceso precoz a centros de referencia de ictus ofrece beneficio clínico: el Código Ictus. Rev Neurol 2008; 47:427- 433.
KIM YS, PARK SS, BAE HJ, CHO AH, CHO YJ, MOON-KU H, ET AL. Stroke awareness decreases prehospital delay after acute ischemic stroke in korea. BMC Neurology 2011, 11:2-8.
SILVA-SIEGER F, ARENAS-BORDA W, ZARRUKSERRANO JG, RESTREPO J, BERNAL-PACHECO O, RAMÍREZ S, ET AL. Factores asociados al tiempo de consulta en pacientes con enfermedad cerebrovascular con enfermedad cerebrovascular isquémica. Rev Neurol 2007; 44: 259-64.
Departamento Administrativo Nacional de Estadística. Estudio Poblacional en Colombia. (citado en octubre 15 de 2008) Disponible en: http://www.dane.gov.co
República de Colombia, Ministerio de Salud. Normas científicas, técnicas y administrativas para investigación en salud. Resolución 008430 del 4 de octubre de 1993. Artículo 11, Numeral b.
KOTHARI R, SAUERBECK L. Patients' Awareness of Stroke Signs, Symptoms, and Risk Factors. Stroke. 1997;28:1871-1875.
YOON SS, HELLER RF, LEVI C, WIGGERS J, FITZGERALD PE. Knowledge of Stroke Risk Factors, Warning Symptoms, and Treatment Among an Australian Urban Population. Stroke 2001;32:1926-1930.
REEVES MJ, HOGAN JG, RAFFERTY AP. Knowledge of stroke risk factors and warning signs among Michigan adults. Neurology. 2002;59:1547-1552.
SEGURA T, VEGA G, LÓPEZ S, RUBIO F, CASTILLO J. Public perception of stroke in Spain. Cereborvascular Dis 2003; 16: 21-26.
PÉREZ-LÁZARO C, IÑÍGUEZ-MARTÍNEZ C, SANTOS-LASAOSA S, ALBERTI-GONZÁLEZ O, MARTÍNEZ-MARTÍNEZ L, TEJERO-JUSTE C, MOSTACERO-MIGUEL E. Estudio sobre el conocimiento de la población acerca del ictus y de los factores de riesgo vascular. Rev Neurol 2009; 49: 113- 118.
PONTES-NETO OM, SILVA GS, FEITOSA MR, DE FIGUEIREDO NL, FIOROT JA JR, ROCHA TN, ET AL. Stroke awareness in Brazil: alarming results in a community-based study. Stroke 2008;39:292-96.
FALAVIGNA A, TELES AR, VEDANA VM, KLEBER FD, MOSENA G, VELHO MC, ET AL. Awareness of stroke risk factors and warning signsin southern Brazil. Arq. Neuro-Psiquiatr. 2009;67: 325-329.
NICOL MB, THRIFT AG. Knowledge of risk factors and warning signs of stroke. Vasc Health Risk Manag 2005; 1:137–147.
MAASLAND L, BROUWER-GOOSSENSEN D, DEN HERTOG H M, KOUDSTAAL PJ, DIPPEL D. Health education in patients with a recent stroke or transient ischaemic attack: a comprehensive review. Intern J Stroke 2011; 6: 67–74.
ORÓ M, SANAHUJA-MONTESINOS J, HERNÁNDEZ L, SETÓ E, PURROY F. Grado de conocimiento del ictus entre población de área rural en la provincia de Lleida. Rev neurol 2009; 48: 515-519.
STROEBELE N, MU¨ LLER-RIEMENSCHNEIDER F, NOLTE CH, MU¨ LLER-NORDHORN J, BOCKELBRINK A, WILLICH SN. Knowledge of risk factors, and warning signs of stroke: a systematic review from a gender perspective. Intern J Stroke. 2011;6:60–66.
JEYARAJ DP, ASHISH J, SUKHBINDER SD, GUNEET K, SHIVALI S, DOUGLAS JL, GEORGE A. Public Awareness of Warning Symptoms, Risk Factors, and Treatment of Stroke in Northwest India. Stroke. 2005;36:644-648.
PANCIOLI AM, BRODERICK J, KOTHARI R, BROTT T, TUCHFARBER A, MILLER R, ET AL. Public Perception of Stroke Warning Signs and Knowledge of Potential Risk Factors. JAMA. 1998;279:1288-1292.
VAN LEIJDEN AJ, WIMMERS RH, HINLOPEN CH, FRANKE CL. Public stroke knowledge and care-seeking intention 2004-2008. The long term impact of an educational mass media campaign in the etherlands. Cerebrovasc Dis 2009; 27(Suppl. 6): 68.
MONTANER J, VIDAL C, MOLINA C, ÄLVA-REZ-SABIN J. Selecting the target and the message for a stroke public education campaign: a local survey conducted by neurologists. Eur J Epidemiol 2001; 17: 581-586.
ANDERSON BE, RAFFERTY AP, LYON-CALLO S, FUSSMAN C, REEVES MJ. Knowledge of tissue plasminogen activator for acute stroke among Michigan adults. Stroke 2009; 40:2564-2567.
KLEINDORFER D, KHOURY J, BRODERICK JP, RADEMACHER E, WOO D, FLAHERTY ML, ET AL. Public knowledge of stroke treatment, warning signs and risk factors during the last decade. Stroke. 2007;38:531-532.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.